Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSActivation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cellsEmbryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein deliveryHematopoietic stem cell development, niches, and signaling pathwaysCnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiationGlucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferationTCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3betaThe WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cellsCore transcriptional regulatory circuitry in human embryonic stem cellsCardiac applications for human pluripotent stem cellsMaintaining embryonic stem cell pluripotency with Wnt signalingThe growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cellsWnt signaling promotes hematoendothelial cell development from human embryonic stem cellsWnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cellsWnt signaling: the good and the badSelf-renewal of embryonic stem cells by a small moleculeCell patterning chip for controlling the stem cell microenvironmentTranscriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapyStem-like features of cancer cells on their way to metastasisAlzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared MechanismsThe Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsTargeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectivesPluripotency Factors on Their Lineage MoveG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingGenerating Diverse Spinal Motor Neuron Subtypes from Human Pluripotent Stem CellsCommon stemness regulators of embryonic and cancer stem cellsRat embryonic stem cells create new era in development of genetically manipulated rat modelsRecent developments in β-cell differentiation of pluripotent stem cells induced by small and large moleculesG Protein-Coupled Receptor Signaling in Stem Cells and CancerEx uno plures: molecular designs for embryonic pluripotencyRole and regulation of β-catenin signaling during physiological liver growthiPSCs and small molecules: a reciprocal effort towards better approaches for drug discoveryGene targeting in mice: a reviewThe immunological synapse: the gateway to the HIV reservoirGPCRs in stem cell functionGSK-3 as potential target for therapeutic intervention in cancerMitotic and mitogenic Wnt signallingThe Rho-Rock-Myosin signaling axis determines cell-cell integrity of self-renewing pluripotent stem cellsE-cadherin-coated plates maintain pluripotent ES cells without colony formation
P2860
Q21129334-5BC4160F-2D90-4B03-BB11-CC329C090613Q21142682-2107FFBF-6A58-4AC9-8540-E6FA6921E7A9Q21147047-4FB03A43-5CF2-405B-8C1C-E3A9D7B3A7E1Q21296679-40494446-FA07-46E6-A419-179B204D3363Q24306322-5DB136A5-E4A8-4DBD-889E-8B8054F26F5AQ24307581-188F08E0-D169-498D-8D48-2C6DCA9A4243Q24311416-FA52B24E-A0A0-4828-AB63-F1F695B577D2Q24321371-D74BC906-346B-4C6F-8CB1-BD807DCF6E99Q24322016-04C94E17-DD18-4643-8870-37CF9DB63C48Q24615347-AEC34FC3-81F0-4A71-8AD6-0C13547AD455Q24635897-94996608-4472-4FA9-803F-7005742AF367Q24648743-A7A1DB26-7F5C-4BC8-98F7-B5716EEA4CE9Q24650908-7EE58C59-D0DC-4909-B9D2-9E0B2EDCC69EQ24651232-458D3210-8B3A-48D0-99E8-B1BEA5DB3CC4Q24653563-714FE0F8-2E51-4FBE-8828-09D57DA810B0Q24676820-483AA125-F4B8-4D0F-A273-0D783C600681Q24685758-56E5BDFE-C32A-4361-94BD-B573F67DE165Q24812873-117DCE03-B990-43EF-802A-534B9DB0F9C8Q26739711-242375D5-6069-464F-BAEC-1F995DB6E9C6Q26741641-017C4372-8B11-42FB-BFD2-51BBB56B1706Q26747569-68388C80-4E71-4EE4-9E1C-944C26924E60Q26765892-65F31747-86BF-4B8E-9729-85361E642616Q26770039-384A67F2-7807-4829-8AB4-C23C50255623Q26771912-D2582C69-07A2-4299-8BA9-D005F13BC3D9Q26772221-109168B8-F08C-47CC-9483-5118257C408DQ26773019-381FDBB4-F599-49AA-9B48-2EBC0A5564A3Q26777882-186E7A6E-E8DB-4070-B35C-954B36B90D38Q26795535-0608555A-362B-4326-A337-553677F41620Q26825664-7BC79196-BEF6-4FE5-9CC3-89E5EE87AB66Q26853233-73876A4B-F84F-4459-9EA6-DE71036CE0E8Q26860750-7C379EDF-7B7C-4797-917A-5F4040CB9F7EQ26864289-73CEF58B-E975-4E61-B791-575614BD73EDQ26865055-17C48496-E910-47B2-A908-EFE48A312E90Q27001077-51978E14-82BE-41FD-9545-53E0A89298CAQ27002959-F772A7CD-CDC8-49B5-84E6-AC7372FB6A08Q27003270-1C9A55FA-0A67-4A5A-9EBC-FB50A0035372Q27013811-7AB210A5-B6FC-4B28-8D73-34BCF5B9A5AFQ27021818-310C355E-FE9E-462C-B278-AF258AA8CD93Q27300727-288F4BA5-EE1A-4BB9-85B0-F2451F3DD57FQ27303234-CC435F3A-833F-4B85-BB05-07060C8B50D8
P2860
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@ast
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@en
type
label
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@ast
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@en
prefLabel
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@ast
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@en
P2093
P3181
P356
P1433
P1476
Maintenance of pluripotency in ...... gical GSK-3-specific inhibitor
@en
P2093
Brivanlou AH
Skaltsounis L
P2888
P3181
P356
10.1038/NM979
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1000301825